This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Treatment of MODY

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

treatment

seek expert advice.

GCK - MODY

  • general consensus is that the majority of these patients do not require treatment since insulin or oral hypoglycaemic agents has little effect on glycemia in this group
  • however in pregnancy insulin may be required to prevent excess fetal growth

HNF1A-MODY and HNF4A-MODY

  • low dose sulfonylureas are recommended as first line treatment for patients with HNF1A/HNF4A-MODY, however most patients will progress to insulin treatment with time
  • a short-acting sulfonylurea such as nateglinide may sometimes be used as an alternative

Reference:

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page